Clinical Outcomes of Surgical Therapy (COST) was a landmark study demonstrating that laparoscopic-assisted colectomy had oncologic outcomes similar to those of open colectomy for colon cancer, but transverse colon cancers (TCCs) were excluded from that study. Oncologic results of a laparoscopic resection for TCC are unknown. This single-institution retrospective 3:1 case-matched review examined patients treated for TCC from January 1, 1996, to April 15, 2009 and open colectomy (OC; extended right, extended left, and total abdominal) cases completed for Stage I to III adenocarcinoma of the transverse colon (hepatic flexure, transverse colon, and splenic flexure) were analyzed. Patients were matched for age, tumor location, and stage. Primary endpoints were overall survival and disease-free survival. Secondary endpoints were length of stay and pathologic parameters. One hundred and twenty-three OC cases were matched with 41 LC cases. There were four conversions (9.7%) in the LC group. Length of stay was reduced by 28% in the LC group (P = 0.02). Complication rate and severity were similar between the two groups (29% vs 24%; P = 0.68). Lymph node harvest was higher in the LC group than in the OC group (23.3 vs 18.6; P = 0.03). All pathologic margins were clear, and no local recurrence was found in either group. Five-year overall survival (61% vs 59%; P = 0.39) and disease-free survival (88% vs 82%; P = 0.23) were similar in the two groups. Short-term recovery was faster and lymph node harvest was improved in the LC group. Thus, laparoscopic management of TCC is a safe and feasible procedure.
T he Clinical Outcomes of Surgical Th erapy (COST) trial demonstrated the oncological equivalence of laparoscopic surgery and open surgery in the treatment of colon cancer (1) . Transverse colon cancers were excluded from the COST trial. It is well known that the laparoscopic management of transverse colon cancers is more challenging than other cancers of the colon. Th is is primarily due to anatomic reasons. Th e transverse colon has at least two collateralizing sources of blood fl ow and therefore multiple possibilities of divergent lymphatic drainage. Th e transverse (middle colic) mesentery is short over the anterior surface of the pancreas, and the venous drainage is fragile at the base of the mesentery. Consideration of tumor site along the transverse colon will infl uence which operation will provide the appropriate extent of mesenteric resection. Th ere are no data regarding the appropriateness of laparoscopic resec-tion for curable cancer from the randomized controlled trials published to date since all excluded transverse colon cancer in their protocols (2) . Th e question of whether laparoscopic surgery is equivalent to open surgery in the management of transverse colon cancer should be addressed before assuming the appropriateness of this technique. Specifi cally, evaluation of 5-year overall survival and disease-free survival for patients undergoing a laparoscopic approach to curable transverse colon cancer is needed.
METHODS
Th e colorectal cancer database containing over 3000 patients at Washington University in St. Louis was queried to obtain patients that would be suitable for our retrospective comparison. Th e study was approved by the institutional review board at Washington University in St. Louis/Barnes Jewish Hospital. All operations were performed by surgeons in the Section of Colon and Rectal Surgery at Washington University in St. Louis from January 1, 1996 according to American Society of Anesthesiologists score >3 or <3 revealed similar groups. Comparison of tumor location along the transverse colon revealed no signifi cant diff erences. Th e tumors were considered hepatic fl exure tumors if they were in the proximal one-third of the transverse colon and were considered splenic fl exure tumors if they were in the distal one-third of the transverse colon.
Th ere were four conversions to open surgery (9.7%) in the laparoscopic group (poor visualization = 3, body habitus = 1). Length of stay was shortened by 28% in the laparoscopic surgery group (P = 0.02) ( Table 1) . Complication rate and severity of complications were similar between the two groups (29% vs 24%; P = 0.68). Th ere were 4 (3.3%) anastomotic leaks in the open group and 2 (4.9%) in the laparoscopic group, and no perioperative deaths. Lymph node harvest was signifi cantly higher in the laparoscopic group than in the open group (23.3 vs Patients underwent extended right colectomy (removal of right and transverse colon), extended left colectomy (removal of left and transverse colon), or total abdominal colectomy based on patient characteristics and tumor location to remove the colon and blood supply to the aff ected area. No segmental, wedge resections were performed for transverse colon cancer. Th e omentum was removed in all patients with transaction of the gastrocolic ligament outside the gastroepiploic arcade along the greater curvature of the stomach. Th e laparoscopic group included laparoscopic-assisted procedures (with intracorporeal dissection and vessel ligation with extraction and anastomosis through a 5 cm midline umbilical incision) and hand-assisted laparoscopic procedures (with the hand port placed at the suprapubic transverse incision used to extract and anastomose the bowel).
Postoperative complications occurring within 30 days of the operation were classifi ed according to the Accordion Severity Grading System of Surgical Complications (ASGS) (3). Mild complications are those that only require a minor procedure at the bedside to resolve. Examples of these include drainage of wound infections and nasogastric tubes. Moderate complications are those that require more aggressive intervention, such as antibiotics, blood transfusions, or total parenteral nutrition. Severe complications are those that require some form of intervention such as an endoscopic procedure, interventional radiologic procedure, or operation. Additionally, severe complications are those that result in the failure of one or more organ system. Th e fi nal classifi cation in the ASGS is death.
Primary endpoints of our study were 5-year overall and disease-free survival. Secondary endpoints were length of stay, complications, and quantity of lymph node retrieval.
Patients were followed by the Section of Colon and Rectal Surgery every 3 months with physical exam and carcinoembryonic antigen level for the fi rst year, at which time colonoscopy and computed tomography (CT) was performed. Patients were followed every 6 months with physical exam and carcinoembryonic antigen level until 5 years. CT scan and colonoscopy were repeated as indicated. Stage III and some stage II patients received adjuvant chemotherapy with 5-fl urouracil-based therapy.
Comparisons were made between the laparoscopic and open groups using unpaired two-tailed t tests for continuous variables and chi-square or Fisher's exact test for categorical variables. Survival was estimated using the Kaplan-Meier method with log rank estimation used to assess diff erences in survival between the two groups. Statistical signifi cance was set at P < 0.05 and results are presented as mean ± standard deviation for continuous variables and as percentages for categorical variables. Statistical analysis was performed using GraphPad 5 Prism Software (San Diego, CA). 18.6; P = 0.03). All pathologic margins were clear. Th ere were no perforations of the cancer or violation of the tumor during the procedure. Operative times were longer for the laparoscopic group. Five-year overall survival was similar between the laparoscopic group and open group (61% vs 59%, respectively; P = 0.39) (Figure 1a) . Th ere was no local recurrence in either group. No diff erences were found when comparing the stage of disease and the method of resection (Figure 1b, 1c, 1d) . Disease-free 5-year survival, comparing all stages together, was 88% and 82% for the laparoscopic and open groups, respectively (P = 0.23) (Figure 2 ).
RESULTS

Patient demographics and tumor characteristics are shown in
DISCUSSION
Th e COST trial excluded patients with transverse colon lesions from its analysis (1) . Th e purpose of this paper was to retrospectively analyze our outcomes for laparoscopic resection of transverse colon cancers when compared to the previous gold standard of open resection. Only three other reports have addressed this issue (4-7). Our data represent the largest review of laparoscopic versus open surgery for transverse colon cancer with long-term follow up.
Th e data presented here support the supposition that laparoscopic resection of transverse colon cancer is feasible and similar to open surgery in experienced hands. Hospital stay is shortened and oncologic outcomes are the same as for open resection. Th e benefi ts of laparoscopic resection are less pain, better cosmesis, improved quality of life, and a shorter recovery without an oncologic or long-term survival detriment. Th ese long-term survival data are consistent with previous data on other site colon resections (2) . Th e complication rate for transverse colectomy is the same for laparoscopic and open techniques (24% vs 29%), and there is no diff erence in the frequency of moderate or severe events. Th e rate of anastomotic leak was also similar.
Laparoscopic resection of transverse colon cancers is considered challenging for laparoscopic surgeons. Exposure at the base of the mesentery is diffi cult. Multiple vessels must be controlled, and vessel-sealing instrumentation has reduced this problem. Injury to the superior mesenteric artery can result from excessive retraction of the colon to expose the base of the middle colic arteries. It is usually during this excessive retraction to obtain exposure that bleeding occurs. Th is was not a problem in this group of patients, and bleeding did not result in an increased conversion to open operation. It is helpful to approach the middle colic vessels from the avascular windows on either side of the middle colic vessels. A familiarity with upper abdominal anatomy is essential. Th is maneuver is facilitated by a hand assist approach. An interesting result of our study was the statistically signifi cant fi nding of a greater lymph node harvest with the laparoscopic approach, 23.3 vs 18.6 lymph nodes (P = 0.03). Th is may refl ect a greater number of total colectomy procedures in the laparoscopic group. Th is could also be a result of better visualization of the base of the middle colic vessels and ligation at a level closer to the surface of the pancreas compared with open surgery. Th e signifi cance of these fi ndings is unclear. Th e higher ligation of the vessels was not associated with an increase in bleeding.
Th e four conversions in the laparoscopic group were primarily a result of poor visualization. One was done for large body habitus. We feel that as we became more adept in laparoscopic resection of transverse colon cancers, our skills allowed us to approach more diffi cult resections without the need for conversion. A conversion rate of 10% is compatible with expected conversion rates for elective laparoscopic colectomy and is less than the rate reported by the COST trial (2) .
Th is report was limited by its retrospective nature and the inherent selection bias that occurs without a randomization process. Th e selection of patients for laparoscopic resection of a transverse colon cancer will be infl uenced by the appearance of the tumor on staging CT. Less advanced tumors will naturally be selected for laparoscopic approaches, and this may infl uence the oncologic outcomes of the patients.
In conclusion, laparoscopic colectomy performed by experienced surgeons for transverse colon cancer is oncologically similar to open colectomy with no signifi cant diff erence in long-term overall or disease-free survival. Short-term recovery and lymph node harvest are improved in the laparoscopic group compared to the open group. Laparoscopic colectomy for transverse colon cancer seems safe and feasible in expert hands, and there is no diff erence in oncologic outcomes.
